Lipid lowering therapy as an important adjunct to stroke prevention in coronary heart disease patients.
Lipid altering pharmacotherapy has been shown to reduce stroke in coronary heart disease (CHD) patients. Several mechanisms of cerebrovascular protection attributed to these agents include reduction in embolic stroke from cardiac, aortic and carotid sites, delayed progression of carotid stenoses, stabilization of vulnerable carotid atherosclerotic plaque and improvement in cerebral blood flow. (c) 2001 Prous Science. All rights reserved.